Built the model before the path to clinical validation and hospital procurement was solved.
Validate the regulatory and distribution path before the product.
I help seed and Series A founders avoid the technical and strategic missteps that quietly kill early-stage companies. I don't write your code. I don't take your equity. I work at the decision and governance level — across technology, product, and strategy as one system.

Most early-stage technical wreckage comes from confusing these roles. Hire the wrong shape of help and you'll burn six months solving the wrong problem.
My job is to stop you from making decisions that could kill the company — not to build the company for you.
No dark patterns. No predatory lending. No products that harm the users they depend on. If the business model needs people to lose for you to win, I'm not the right advisor.
Regulatory exposure, trust-sensitive data, and partner dependencies make early technical and compliance choices unusually expensive to reverse.
Clinical validation, procurement realities, and patient-safety rules mean the wrong day-one architecture can quietly close every meaningful door.
Part-time, ongoing technical leadership without a full-time hire. I operate at the decision and governance layer — technology strategy, vendor oversight, build-vs-buy calls, and keeping your technical direction aligned with your business model as you scale from seed to Series A.
A structured technical review of your stack, architecture decisions, security posture, and team structure — presented as an investor would see it. Identify the gaps before your investors do, and walk into your raise with the answers ready.
A systematic assessment of the decisions that could silently kill your company — over-engineered or under-engineered architecture, dangerous vendor dependencies, regulatory blind spots, and premature scaling commitments. Delivers a prioritized risk register, not a general report.
Translating your business objectives into a coherent, sequenced technical plan. Covers what to build, what to buy, what to defer, and in what order — structured around your funding runway and the stage you're actually at, not the stage you plan to be at.
Helping founders define the right technical roles at the right time — whether that's a lead engineer, a co-founder, or no technical hire yet. Includes role definition, seniority calibration, and interview criteria so you evaluate candidates against what the stage actually demands rather than a generic job description.
Mapping the specific regulatory obligations your startup will face — KYC/AML, PSD2, HIPAA, MDR, or others depending on your market — and assessing how early your technical and operational decisions need to accommodate them. Targeted at Fintech and Healthtech startups in the EMEA region where regulatory exposure is unusually high and mistakes are unusually expensive.
No testimonials. No invented wins. The credibility here is that I've already paid the tuition on the mistakes you're about to make.
Built the model before the path to clinical validation and hospital procurement was solved.
Validate the regulatory and distribution path before the product.
Anchored to token economics and speculative volume instead of durable banking infrastructure and compliance partnerships.
A fintech product can't depend on the market staying excited.
Strong product sold into an SMB segment that couldn't sustain enterprise-length sales cycles or security budgets.
Product quality doesn't substitute for knowing who can actually pay.
// Illustrative summaries — exact causes available on request.
Each one is grounded in a named framework and produces a concrete output — a score, a checklist, or a specific next step. No email gate.
Three-time startup founder, currently building a new venture. A decade of R&D and product development experience, primarily across the EMEA region.
Strategy calls are application-only. I take on a small number of founders per quarter so the work stays honest.